HOME >> BIOLOGY >> NEWS
William C. Aird, MD, receives Established Investigator Award from American Heart Association

BOSTON William C. Aird, MD, Associate Director of the Vascular Biology Research Center at Beth Israel Deaconess Medical Center (BIDMC), has been named the recipient of a 2005 Established Investigator Award from the National Research Committee of the American Heart Association (AHA).

One of only 25 scientists to receive the AHA's prestigious award, which consists of a five-year $500,000 grant, Aird specializes in investigating endothelial cell heterogeneity, widely believed to play a critical role in both homeostasis and vascular disease states. Aird's laboratory will use the award in their continued investigations of the mechanisms that underlie differential gene expression within the endothelium and to gain a better understanding of how the endothelial cells lining the body's blood vessels are differentially regulated in space and time.

"Bill Aird's work has greatly advanced our thinking about the critical role of the endothelium to health and disease states," notes Jeffrey S. Flier, MD, BIDMC's Chief Academic Officer. "This well-deserved honor from the AHA further serves to demonstrate the fundamental importance of this area of research within the field of medicine."

A graduate of The University of Western Ontario Medical School, Aird completed residencies at St. Michael's Hospital and Toronto General Hospital, teaching hospitals of the University of Toronto. Before joining BIDMC in 1996, he held both clinical and research fellowships in medicine at Brigham and Women's Hospital, and was a postdoctoral fellow in the Department of Biology at the Massachusetts Institute of Technology. He is an Associate Professor of Medicine at Harvard Medical School.

Beth Israel Deaconess Medical Center is a patient care, teaching and research affiliate of Harvard Medical School, and ranks third in National Institutes of Health funding among independent hospitals nationwide. BIDMC is clinically affiliated with the Joslin Diabetes Center and is a res
'"/>

Contact: Bonnie Prescott
bprescot@bidmc.harvard.edu
617-667-7306
Beth Israel Deaconess Medical Center
10-Feb-2005


Page: 1 2

Related biology news :

1. SNMTS provides $50,000 in 2007 Paul Cole, Mickey Williams Minority Student Technologist Scholarships
2. Williams College biologist explores photosynthetic apparatus
3. Beyond nature vs. nurture: Williams syndrome across cultures
4. APS research awards go to undergrads at Colorado State, Michigan State, Oberlin, Williams
5. Lawrence Platt, MD, receives the 2006 AIUM William J. Fry Memorial Lecture award
6. NSF awards support for DNA analysis instrumentation lab at Williams College
7. Society of Nuclear Medicine to offer $10,000 William L. Ashburn, M.D., Pilot Research Grant for 2006
8. William C. Rose Award lecture will focus on cytochrome P450
9. Carnegie Mellons Peter Adams receives EPA research grant
10. Philadelphia ecologist receives top Mongolia honor
11. VIB scientist receives major research grant

Post Your Comments:
(Date:2/23/2015)... , Feb. 23, 2015 NXT-ID, Inc. (NASDAQ: ... "Company"), a biometric authentication company focused on the growing ... provisional patent 62114357 for DISTRIBUTED VOICE DIRECTED ... NXT-ID introduces a new groundbreaking payment method. Payment accounts ... account may only be accessed if both the speech ...
(Date:2/12/2015)... Feb. 12, 2015   MedNet Solutions , ... clinical study management systems, has recently bolstered its ... distinguishing iMedNet as the ... (CROs) and healthcare consultants.  Building on the Program,s ... referrals and numerous co-marketing opportunities), MedNet,s new and ...
(Date:2/9/2015)... Texas , Feb. 9, 2015  Lintec of ... fabrication methods for carbon nanotube (CNT) macrostructures, including sheets, ... at Dallas (UTD). Leveraging the vast industrial ... Tokyo, Japan , Lintec of America is ... Richardson, TX , focusing on scaling up ...
Breaking Biology News(10 mins):NXT-ID Patents Voice Directed Payments 2NXT-ID Patents Voice Directed Payments 3MedNet Solutions Announces Key Enhancements To Its iMedNet Partner Program 2Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 2Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 3Lintec announces exclusive license to commercialize innovative carbon nanotube technology from the University of Texas at Dallas 4
(Date:2/26/2015)... , Feb. 26, 2015 /PRNewswire/ - SQI Diagnostics Inc. ... life sciences company that develops and commercializes proprietary technologies ... financial and operational results for the fiscal first quarter ... release are in Canadian dollars (CAD), unless otherwise stated. ... to win new business from our existing customers and ...
(Date:2/26/2015)... Feb. 26, 2015   Regulus Therapeutics Inc . ... the discovery and development of innovative medicines targeting microRNAs, ... President and Chief Executive Officer of Regulus, will present ... th Annual Healthcare Conference on Wednesday, March 4, ... held at the Boston Marriott Copley Place.  ...
(Date:2/26/2015)... , Feb. 26, 2015 DuPont Executive ... priorities driven by key research advancements and product launches ... today,s Bank of America Merrill Lynch 2015 Global Agriculture ... challenge of building grain supplies the last two years, ... at the pace of the last decade, when demand ...
(Date:2/26/2015)... NJ (PRWEB) February 26, 2015 On ... and its affiliated companies, Wilentz, Goldman & Spitzer, ... a trade secrets lawsuit against Genewiz Inc. in excess ... obtained and utilized GenScript’s trade secrets, and that it ... The court entered an order denying motions for judgment ...
Breaking Biology Technology:SQI Diagnostics Reports First Quarter Financial Results 2SQI Diagnostics Reports First Quarter Financial Results 3SQI Diagnostics Reports First Quarter Financial Results 4SQI Diagnostics Reports First Quarter Financial Results 5SQI Diagnostics Reports First Quarter Financial Results 6Regulus to Present at Cowen and Company 35th Annual Healthcare Conference 2Regulus to Present at Cowen and Company 35th Annual Healthcare Conference 3DuPont Leader Outlines Path for Growth in Agriculture and Nutrition & Health Segments 2DuPont Leader Outlines Path for Growth in Agriculture and Nutrition & Health Segments 3DuPont Leader Outlines Path for Growth in Agriculture and Nutrition & Health Segments 4DuPont Leader Outlines Path for Growth in Agriculture and Nutrition & Health Segments 5Wilentz Client GenScript Awarded $10 Million in Trade Secrets Case Against Genewiz 2Wilentz Client GenScript Awarded $10 Million in Trade Secrets Case Against Genewiz 3
Cached News: